Spectra XT, made by Lutronic and distributed by Advanced Cosmeceuticals, uses state-of-the-art technology and two new wavelengths to achieve maximum tattoo clearance and optimal skin rejuvenation.
Around 35 per cent of ink- bearing Australians regret their decision to get a tattoo, according to CHOICE, the consumer watchdog in Australia. Thankfully, due to the rise and refinement of tattoo removal technology, it now possible to undo these decisions with greater clearance and patient satisfaction than ever before.
Spectra XT Laser from Lutronic, distributed in Australia by Advanced Cosmeceuticals, is a permanent solution to tattoo removal. It is a Dual Mode Q-switched Nd:YAG Laser designed to significantly lighten or completely remove tattoo ink from the skin. It is also used in general skin rejuvenation and to treat melasma, active acne and pigmentation.
The Spectra XT laser calls upon photothermolyis to generate change in the skin. It delivers high peak power (max 1.2 Joules) in short pulse widths (5-10 nanoseconds) to break down target chromophores more effectively, without causing excessive thermal damage.
This minimises post-procedure inflammation, thus preventing side effects such as post-inflammatory hyperpigmentation (PIH).
Spectra XT uses a Top Hat Beam Profile to regulate beam consistency. This means there are no hot spots created during treatment and
the energy distributed is uniform – reducing the chances of post- procedure blisters and contributing to the desired clinical outcome.
Spectra XT’s Auto-Detection of the Handpiece Spot Size makes treatment easier than ever to perform. The spot size displayed on the machine is automatically adjusted according to the spot size determined on the hand piece.
This ensures the right fluences are automatically delivered from the device, based on the information determined by the practitioner on the handpiece.
The targeted nature of Spectra XT treatment means the surrounding dermis and epidermis remain untouched. This helps boost recovery and improve skin condition following treatment.
Pulse to Pulse analysis
Pulse to Pulse (PTP) Analysis measures the stability of the wavelength, and any difference – or energy deviation – between the pulses. A consistent pulse delivery, with minimum energy deviation, is preferred in both skin rejuvenation and tattoo removal, as it ensures the provision of effective treatment and expected clinical outcomes.
Spectra XT PTP analysis is very stable compared to other systems, particularly at the 523 nanometre wavelength. Its PTP Analysis shows a deviation rate of below 10 per cent, compared to around 30 per cent as exhibited by other systems.
Tattoo removal with Spectra XT
Traditionally, green and blue ink pigments have been very difficult to treat in tattoo removal. However, according to a paper by laser specialist and president of the European Society of Aesthetic Plastic surgery Dr Mario A. Trelles, Spectra XT’s 523 nm wavelength can achieve significant results in reducing red, green and brownish pigment.
The number of Spectra XT treatments required to achieve optimal results usually ranges between one and ten, depending on the size, positioning, depth and colour of the tattoo.
Following each treatment, the body needs four to eight weeks to flush the fragmented ink particles from the site, and patients should wait at least four weeks before undergoing the second treatment.
Dr Trelles found the best results were achieved in the first session, and recommended using higher energy doses in the initial treatment – particularly in dense areas of multiple colours – to achieve optimum results.
Visit www.advancedcosmeceuticals.com.au or call 1800 242 011
Introducing new Wavelengths
The latest generation of Spectra – Spectra XT EX – has released two new wavelengths – 595 nm and 660 nm. The 595 nm wavelength is readily absorbed into oxyhaemoglobin, targeting ectatic blood vessels, and is relatively resistant to deoxyhaemoglobin, giving it easier penetration to reach the problematic arterial blood vessels in inflammation-mediated skin disorders. It is effective in reducing the redness that sometimes arises following treatment of acne lesions.
The 660 nm handpiece is highly absorbed in melanin, but is significantly less well absorbed in blood. This makes it a safer treatment, helping to minimse inflammation in the epidermis.
‘The 660nm handpiece is ideal for treating discrete epidermal pigmented lesions,’ explains Dr Bettina Rummelein, a dermatologist practicing in Kilchberg/Zurich, Switzerland. ‘The 532nm has associated side-effects with unattractive crusting or bleeding, these are significantly reduced with the 660nm. Concealing makeup is therefore not needed in the short-term post-treatment.’